% Expired Patents = 50.0

EPO Patents = 1

Trademarks = 1

Forward Citations = 10

Loading Chart...

4 inventors (with patents filed for the assignee):

Mark Tepper (6 out of 14 patents)

Dean A Frey (4 out of 4 patents)

David Goeddel (4 out of 4 patents)

4. Karl Reineke (4 out of 9 patents)

5. Robert B Zurier (4 patents)

6. Enrico Selvi (0 patent)

6 patents: Sort by Forward Citations

1. 11052066 - Ultrapure tetrahydrocannabinol-11-oic acids (2021-07-06),

2. 10369131 - Ultrapure tetrahydrocannabinol-11-oic acids (2019-08-06),

3. 10154986 - Ultrapure tetrahydrocannabinol-11-oic acids (2018-12-18),

4. 10085964 - Ultrapure tetrahydrocannabinol-11-oic acids (2018-10-02),

5. 9820964 - Ultrapure tetrahydrocannabinol-11-oic acids (2017-11-21),

6. 9801849 - Ultrapure tetrahydrocannabinol-11-oic acids (2017-10-31),

Company Overview

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The company's lead product candidate, lenabasum, is a synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Corbus is committed to improving the lives of patients through innovative treatments.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#22 in Norwood, MA

#2,546 in Massachusetts

#45,007 in US

Norwood, MA, United States of America

Corbus Pharmaceuticals, Inc.

Forward Citations = 10

4 inventors:

Mark Tepper (6 out of 14 patents)

Dean A Frey (4 out of 4 patents)

David Goeddel (4 out of 4 patents)

4. Karl Reineke (4 out of 9 patents)

5. Robert B Zurier (4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Corbus Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/corbus-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]